Trafalgar International GCAN
OTC GCAN
$0.35 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Trafalgar International (GCAN) Total Non-Current Liabilities (2016 - 2021)

Trafalgar International (GCAN) posted Total Non-Current Liabilities of $460651.0 for Q1 2021, up 4.11% on a QoQ basis from $442467.0 in Q4 2020, and down 53.71% year-over-year from $995119.0 in Q1 2020.

Analysis

Trafalgar International (GCAN) Total Non-Current Liabilities (2016 - 2021) Analysis & Trends

Trafalgar International has reported Total Non-Current Liabilities for 6 years, with the latest figure at $460651.0 in Q1 2021.

  • On a quarterly basis, Total Non-Current Liabilities fell 53.71% year-over-year to $460651.0 in Q1 2021; TTM through Mar 2021 was $460651.0, a 53.71% decrease from a year earlier, with the FY2020 full-year figure at $442467.0, down 72.03% from the prior year.
  • Total Non-Current Liabilities was $460651.0 for Q1 2021 at Trafalgar International, up from $442467.0 in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $1.6 million in Q4 2019, with the low at -$205403.0 in Q4 2017.
  • Average Total Non-Current Liabilities over 5 years is $511429.1, with a median of $459956.0 recorded in 2019.
  • The sharpest annual moves came in 2017 and 2018: Total Non-Current Liabilities plunged 2437.31% in 2017, then surged 394.54% in 2018.
  • Over 5 years, Total Non-Current Liabilities stood at -$205403.0 in 2017, then surged by 394.54% to $604999.0 in 2018, then surged by 161.46% to $1.6 million in 2019, then tumbled by 72.03% to $442467.0 in 2020, then advanced by 4.11% to $460651.0 in 2021.
  • The last three Total Non-Current Liabilities figures came in at $460651.0 (Q1 2021), $442467.0 (Q4 2020), and $599261.0 (Q3 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 105.99 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 106.45 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 16.16 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 48.34 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 100.86 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 32.04 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 1.53 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 1.40 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 607.80 Mn
10 Trafalgar International 217,335.05 217,335.05 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 460,651.00
Dec 31, 2020 442,467.00
Sep 30, 2020 599,261.00
Jun 30, 2020 774,453.00
Mar 31, 2020 995,119.00
Dec 31, 2019 1.58 Mn
Sep 30, 2019 508,947.00
Jun 30, 2019 459,956.00
Mar 31, 2019 409,882.00
Dec 31, 2018 604,999.00
Sep 30, 2018 401,874.00
Jun 30, 2018 274,624.00
Mar 31, 2018 217,776.00
Dec 31, 2017 -205,403.00
Sep 30, 2017 144,976.00
Dec 31, 2016 8,788.00